161.59
price up icon0.19%   +0.31
pre-market  プレマーケット:  161.26   -0.33   -0.20%
loading

Abbvie Inc (ABBV) 最新ニュース

Will Pharma And Healthcare Have Competitive Edge In Cannabis Post-Rescheduling? Data Analytics Expert Weighs In

pulisher
Benzinga

AbbVie (ABBV) Boosts Neuropsychiatric Portfolio With New Deal

pulisher
Zacks Investment Research

Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know

pulisher
Zacks Investment Research

3 Magnificent Stocks That Are Passive Income Machines

pulisher
The Motley Fool

What Is the Dividend Payout for AbbVie Stock?

pulisher
The Motley Fool

Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks

pulisher
Zacks Investment Research

My Dividend Growth Portfolio: Selling Bio-Pharma And Buying More Big-Tech

pulisher
Seeking Alpha

Earn $1000 Every Month From These 3 Stocks

pulisher
The Motley Fool

Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.

pulisher
The Motley Fool

Ironwood (IRWD) Q1 Earnings & Revenues Fall Shy of Estimates

pulisher
Zacks Investment Research

3 Rock-Solid Dividend Stocks That Are Ideal for Retirees

pulisher
The Motley Fool

TEVA Q1 Earnings Miss, Schizophrenia Study Meets Goal, Stock Up

pulisher
Zacks Investment Research

3 Top Dividend Stocks to Maximize Your Retirement Income

pulisher
Zacks Investment Research

Should First Trust Morningstar Dividend Leaders ETF (FDL) Be on Your Investing Radar?

pulisher
Zacks Investment Research

3 Reasons to Buy AbbVie Stock on the Dip

pulisher
The Motley Fool

Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims

pulisher
Zacks Investment Research

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

pulisher
Zacks Investment Research

Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock

pulisher
Zacks Investment Research

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

pulisher
Zacks Investment Research

Is WisdomTree U.S. Quality Dividend Growth ETF (DGRW) a Strong ETF Right Now?

pulisher
Zacks Investment Research

AbbVie (ABBV) Could Be a Great Choice

pulisher
Zacks Investment Research

3 Top Dividend Stocks to Maximize Your Retirement Income

pulisher
Zacks Investment Research

Peeling Back The Layers: Exploring AbbVie Through Analyst Insights

pulisher
Benzinga

Better Dividend Stock: AbbVie or Johnson & Johnson?

pulisher
The Motley Fool

3 Dividend Stocks to Buy and Hold for the Next Decade

pulisher
The Motley Fool

Why AbbVie Stock Stumbled Today Despite the Earnings Beat

pulisher
The Motley Fool

AbbVie (ABBV) Q1 2024 Earnings Call Transcript

pulisher
The Motley Fool

Tech Stocks Rebound As Magnificent 7 Roar On Strong Earnings, Energy Giants Tumble: What's Driving Markets Friday?

pulisher
Benzinga

AbbVie (ABBV) Beats on Q1 Earnings & Sales, Ups '24 EPS View

pulisher
Zacks Investment Research

PCE/Core PCE Numbers Came In Line With Expectations

pulisher
Zacks Investment Research

PCE In-Line to Warmer, Pre-Market Calms; ABBV Beats, XOM Misses

pulisher
Zacks Investment Research

AbbVie (ABBV) Reports Q1 Earnings: What Key Metrics Have to Say

pulisher
Zacks Investment Research

AbbVie (ABBV) Beats Q1 Earnings and Revenue Estimates

pulisher
Zacks Investment Research

Wall Street Futures Ride High On Microsoft, Alphabet Cheer, But Will Inflation Data Burst The Bubble? Why This Analyst Thinks Bull Run Isn't Over Yet

pulisher
Benzinga

Is ProShares S&P 500 Dividend Aristocrats ETF (NOBL) a Strong ETF Right Now?

pulisher
Zacks Investment Research

Zacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, Merck and AbbVie

pulisher
Zacks Investment Research

Will Healthcare ETFs Lose Momentum as Q1 Earnings Unfold?

pulisher
Zacks Investment Research

4 Large Drug Stocks to Hold on to Amid Industry Challenges

pulisher
Zacks Investment Research

What's in Store for These 5 Pharma Bigwigs in Q1 Earnings?

pulisher
Zacks Investment Research

Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now?

pulisher
Zacks Investment Research

Eli Lilly (LLY) Reports Next Week: Wall Street Expects Earnings Growth

pulisher
Zacks Investment Research

Gear Up for AbbVie (ABBV) Q1 Earnings: Wall Street Estimates for Key Metrics

pulisher
Zacks Investment Research

Not A Millionaire? No Problem! Here's A 10-Stock Portfolio To Retire Comfortably

pulisher
Seeking Alpha

Should Pacer US Cash Cows 100 ETF (COWZ) Be on Your Investing Radar?

pulisher
Zacks Investment Research

AbbVie (ABBV) to Report Q1 Earnings: What's in the Cards?

pulisher
Zacks Investment Research

Buying the Dip in These 3 Undervalued Dividend Stocks

pulisher
The Motley Fool

Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks

pulisher
Zacks Investment Research

Is Pacer US Cash Cows 100 ETF (COWZ) a Strong ETF Right Now?

pulisher
Zacks Investment Research

Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week

pulisher
Benzinga

Wall Street Breakfast: The Week Ahead

pulisher
Seeking Alpha
drug_manufacturers_general MRK
$128.66
price down icon 0.49%
drug_manufacturers_general NVS
$103.31
price up icon 1.03%
drug_manufacturers_general JNJ
$151.38
price up icon 0.11%
$311.41
price up icon 0.96%
drug_manufacturers_general PFE
$28.38
price down icon 0.21%
大文字化:     |  ボリューム (24 時間):